Drugs News and Research

RSS

Damon Runyon Cancer Research Foundation names 18 new Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 18 new Damon Runyon Fellows at its fall Fellowship Award Committee review.

11 Jan 2012

uVera Diagnostics introduces CR3 Keyless Split Sample Cup for drug screening

uVera Diagnostics has introduced the CR3 Keyless Split Sample Cup to its inventory. The new drug screening specimen cup provides several state-of-the-art features not available together in any other product on the market.

11 Jan 2012

Inherited breast and ovarian cancer drug trial re-launched in tablet form

Cancer Research UK's Drug Development Office has re-launched a trial of a promising drug to treat inherited breast and ovarian cancer - but this time taken as a tablet by outpatients.

11 Jan 2012

New possibilities for effective treatment of psoriasis

Researchers at Link-ping University in Sweden are now launching a plan to effectively treat psoriasis.

11 Jan 2012

Research identifies several new means to potentially target cancer

Scientists at the University of Leicester have opened up a whole new approach to the therapeutic intervention for a family of anti-cancer drug targets, thanks to a completely new and unexpected finding.

11 Jan 2012

2010 health spending grew slowly

This slowing of health spending brought the rate of growth in line with that of the U.S. economy. The Obama administration pointed to the new figures as evidence that the health law isn't making health care more expensive.

11 Jan 2012

UCLA researchers identify chemical changes in brains of patients with early-onset Alzheimer's

With a lack of effective treatments for Alzheimer's, most of us would think long and hard about whether we wanted to know years in advance if we were genetically predisposed to develop the disease. For researchers, however, such knowledge is a window into Alzheimer's disease's evolution.

11 Jan 2012

Infectious disease-fighting drugs could be designed to block pathogen's entry into cells

New research shows that infectious disease-fighting drugs could be designed to block a pathogen's entry into cells rather than to kill the bug itself.

11 Jan 2012

Warwick researchers and Canadian scientists partner in new project on antibiotic resistance

University of Warwick researchers have teamed up with Canadian scientists on a -2.2 million project to search for new antibiotics which will beat resistance in deadly "superbugs".

11 Jan 2012

Cancer cells feed on sugar-free diet

Cancer cells have been long known to have a “sweet tooth,” using vast amounts of glucose for energy and for building blocks for cell replication.

10 Jan 2012

Nicotine patch may help those with mild dementia

The nicotine patch designed to help people quit smoking can also improve memory in older adults with mild cognitive impairment, or MCI, a small clinical trial found.

10 Jan 2012

Statins may raise type 2 diabetes risk

A new study suggests statin medications used to lower cholesterol may raise the risk of diabetes to a slight extent. Study authors advise patients not to stop taking their medications without talking to a doctor, because statins' proven power to prevent heart attacks and strokes outweighs any potential increase in type 2 diabetes risk.

10 Jan 2012

Questions raised over nicotine replacement therapy: Study

Smokers have been advised a host of choices for nicotine replacement like gums, patches and nasal sprays to help them quit. But a new U.S. study says that these do not help people quit cigarettes over the long term any better than going it alone.

10 Jan 2012

Personalized medicine could offer a valuable tool to help combat the diabetic epidemic

With the trend in healthcare moving toward an era of personalized medicine, there is much anticipation and hope that customized approaches to prevention and treatment based on a person's genetic make-up will result in better health outcomes. Some advances, most notably with prevention and treatment of breast and colon cancer, have been widely heralded, raising questions about the potential for personalized medicine for other common diseases, such as diabetes.

10 Jan 2012

ORMOSIL nanoparticles show promise as potential drug delivery vehicle

In the images of fruit flies, clusters of neurons are all lit up, forming a brightly glowing network of highways within the brain. It's exactly what University at Buffalo researcher Shermali Gunawardena was hoping to see: It meant that ORMOSIL, a novel class of nanoparticles, had successfully penetrated the insects' brains. And even after long-term exposure, the cells and the flies themselves remained unharmed.

10 Jan 2012

Concerns over using ARV therapy as prevention strategy

PSI's "Healthy Lives" blog reviews a recent Science magazine article written by James Shelton of USAID's Bureau of Global Health in which he raises concerns about the use of antiretroviral drugs (ARVs) as a prevention strategy.

10 Jan 2012

Delaying hypertension treatment in diabetic patients for up to a year is unlikely to be harmful

Confronted with a high blood pressure value in a diabetic patient, most doctors would treat aggressively with medications. According to new research, however, delaying drug treatment for up to a year is unlikely to be harmful. The delay allows doctors and their patients to focus on lifestyle changes such as salt restriction, weight management, and exercise.

10 Jan 2012

Cardiologist measures risk factors associated with CR

The cardiologist Aitor Jim-nez has managed to gather and characterise in detail 110 cases of cardiac rupture (CR), after spending 22 years (1978-2000) gathering data at the Hospital de Cruces, near Bilbao. It is one of the broadest anatomical series described in this respect. CR is the most serious complication of acute myocardial infarction; it is not very common, but when it does occur, it is mortal in practically all cases. So prevention, although difficult, seems more feasible than cure.

10 Jan 2012

MAL3-101 appears to have potent anti-tumor effects on multiple myeloma

A new study from SUNY Downstate Medical Center in Brooklyn, New York, shows that MAL3-101, a recently developed inhibitor of the heat shock protein 70 (Hsp70), appears to have potent anti-tumor effects on multiple myeloma, a bone marrow cancer.

10 Jan 2012

QIAGEN's therascreen EGFR Mutation Detection Kit receives Japanese regulatory approval

QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.

From QIAGEN Manchester Limited 10 Jan 2012